Keyphrases
Systemic Sclerosis
87%
Scleroderma
74%
Rheumatoid Arthritis
49%
Systemic Lupus Erythematosus
47%
Psoriatic Arthritis
36%
Diffuse Cutaneous Systemic Sclerosis
33%
Infliximab
33%
Vaccination
31%
EUSTAR
30%
Disease Activity
24%
Immunogenicity
23%
Antiphospholipid Syndrome
23%
Autoantibodies
22%
Research Cohort
20%
Risk Factors
20%
Digital Ulcers
20%
Rheumatoid Arthritis Patients
19%
Modified Rodnan Skin Score (mRSS)
19%
Healthy Controls
19%
Methotrexate
18%
Influenza
17%
Skin Fibrosis
17%
Tumor Necrosis Factor-α Blocker
15%
Humoral Response
15%
DcSSc
13%
European League against Rheumatism (EULAR)
13%
Disease Progression
12%
Adalimumab
12%
Clinical Analysis
12%
Research Analysis
12%
Furosemide
11%
Pneumococcal Vaccination
11%
Impaired Learning
11%
Impaired Memory
11%
Learnability
11%
Nitrate Tolerance
11%
Autoimmune Inflammatory Rheumatic Disease
11%
Memory Ability
11%
Captopril
11%
Early Course
11%
Group Studies
11%
Ex Vivo Studies
11%
Disease Duration
11%
Arthritis Patients
11%
Odds Ratio
10%
Disease Pattern
10%
Synovial Fluid Mononuclear Cells
10%
Geometric Mean Titer
10%
Raynaud's Phenomenon
10%
Ankylosing Spondylitis
9%
Immunology and Microbiology
Systemic Scleroderma
100%
Scleroderma
57%
Inflammatory Arthritis
48%
Vaccination Policy
43%
Autoantibodies
31%
Infliximab
30%
Influenza
25%
Psoriatic Arthritis
24%
Immunogenicity
23%
Tumor Necrosis Factor
23%
Systemic Lupus Erythematosus
18%
Prevalence
17%
Humoral Immunity
14%
Glucocorticoid
13%
Methotrexate
12%
Vaccine Efficacy
12%
Synovial Fluid
12%
Monospecific Antibody
10%
Ankylosing Spondylitis
9%
Raynaud Phenomenon
8%
Mononuclear Cell
8%
Rituximab
8%
Influenza A Virus (H1N1)
7%
C-Reactive Protein
7%
Influenza Virus
7%
Titer
6%
Rheumatic Disease
6%
Antiinflammatory Activity
6%
Synovitis
6%
Osteoarthritis
6%
Monocyte
6%
Disease-Modifying Antirheumatic Drug
6%
TNF Inhibitor
6%
Tumor Necrosis Factor Alpha
6%
Synovial Fluid Level
5%
Population
5%
Fibroblast-Like Synoviocyte
5%
Antinuclear Antibody
5%
Sputum
5%
Rheumatoid Factor
5%
Race Difference
5%
Vasculitis
5%
Immunoglobulin A
5%
Anti-Citrullinated Protein Antibody
5%
Fibroblast
5%
COVID-19
5%
Influenza Vaccine
5%
Adalimumab
5%
Hemagglutination Inhibiting Antibody
5%
Influenza A Virus (H3N2)
5%
Medicine and Dentistry
Systemic Scleroderma
88%
Scleroderma
45%
Systemic Lupus Erythematosus
30%
Autoantibodies
23%
Disease
18%
Rheumatoid Arthritis
17%
Antiphospholipid Syndrome
17%
Skin Fibrosis
17%
Disease Activity
16%
Rheumatic Disease
12%
Infliximab
11%
Disease Exacerbation
11%
Disease Duration
11%
Interstitial Lung Disease
8%
Raynaud Phenomenon
8%
Methotrexate
8%
Finger Ulcer
7%
Humoral Immunity
7%
Influenza A Virus (H1N1)
7%
Induced Sputum
6%
Diastolic Dysfunction
6%
Antinuclear Antibody
5%
Oxime
5%
Rey Auditory Verbal Learning Test
5%
Vasculitis
5%
Injury
5%
Latent Tuberculosis
5%
Bronchiolitis Obliterans Organizing Pneumonia
5%
Leukocyte
5%
Glucocorticoid
5%
Health Assessment Questionnaire
5%
Acute Heart Infarction
5%
Lenabasum
5%
Receptor
5%
Tuberculosis
5%
Adalimumab
5%
Psoriatic Arthritis
5%
Enthesis
5%
Spondyloarthropathy
5%
Ankylosing Spondylitis
5%
Abdominal Scintiscanning
5%
Prospective Study
5%
Sputum Analysis
5%
Major Bleeding
5%
Technetium-99
5%
Bleeding
5%
Propylthiouracil
5%
Heart Disease
5%
Blood Clot Lysis
5%
Influenza Vaccination
5%
